79 Diagnostic Utility of DNA Methylation Profiling in CNS Tumors: A Comparative Study of FFPE and Fresh-Frozen Tissues

Clicks: 24
ID: 326762
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #83 of 286 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction DNA methylation–based classification has become an essential adjunct to histopathology in central nervous system (CNS) tumor diagnostics. Although both fresh-frozen and formalin-fixed paraffin-embedded (FFPE) tissues are used for methylation profiling, comparative real-world data on their diagnostic performance remain limited. Methods We analysed 179 CNS tissue samples (162 tumors, 17 non-neoplastic controls), comprising 42 FFPE and 137 fresh-frozen specimens, all with ≥50% tumor cellularity. Genome-wide DNA methylation profiling was performed using Illumina Infinium EPIC/EPIC v2.0 arrays. Classification was carried out using the DKFZ Brain Tumor Classifier (versions 11b–12.8) and independently validated with the NIH Methylscape classifier. Classifier outputs were correlated with histopathological diagnoses and categorised as confirmed, refined, changed, or unclassified. Results Overall classification success was higher in FFPE samples compared with fresh-frozen tissue (98% vs. 92%). High-confidence classification (calibrated score >0.9) was achieved in 62% of FFPE and 74% of fresh-frozen cases. Despite this, discordant or misleading classifications were predominantly observed in fresh-frozen samples (8% of discordant cases), largely attributable to sampling bias and low effective tumor content. FFPE samples demonstrated superior diagnostic refinement (67%) and a lower rate of unsatisfactory or misleading results (2%). Methylation profiling resulted in diagnostic confirmation or refinement in the majority of cases and led to a revised diagnosis in a clinically significant subset. Conclusion DNA methylation profiling is a robust diagnostic adjunct for CNS tumors using both FFPE and fresh-frozen tissue. In routine practice, FFPE specimens show more consistent performance, likely due to histologically guided sampling and reduced tissue heterogeneity, supporting their reliable use in methylation-based diagnostics.
Reference Key
openalex_W7204468047 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jyotsna Singh, Shabnam Mansoori, Ashish Suri, Vaishali Suri
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.054
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.054/70805953/noag172.054.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.